Female Pattern Baldness – New Study Evaluates the Treatments on Offer

examined and evaluated the treatments available for Female pattern baldness, or androgenetic alopecia as it is also known.

What is Female Pattern Baldness?

The condition can be distressing, with the frontal hair line and hair on top of the head often thinning and creating life changing psychological effects. These might include feelings of unattractiveness, shame and low self-esteem. The condition can occur at any time from puberty until old age but is most common post the menopause.

The review was based on a number of a number of articles from various medical journals and databases and included 47 trials and 5290 participants with the aim of establishing the efficacy of the various treatments available.

Main Treatments

The review focused on three main groups of treatment:

1. Topical minoxidil, applied directly to the scalp. This compound works by keeping the hair follicles in the growing stage for longer and 2% and 5% doses were reviewed.

2. Finasteride (taken orally). This treatment is usually only prescribed to men for hair loss treatment.

3. Low Level Laser Therapy (LLLT). This treatment relies upon increasing blood circulation to the scalp in an attempt to encourage growth of hair follicles.

Two main conclusions could be drawn from the review. The first is that the quality of evidence in the trials could only be rated as moderate to low due to the sample sizes and the risk of bias.

Secondly Minoxidil was the only treatment which showed significant hair regrowth against placebo groups with an important increase in total hair count per cm².

The finasteride trials showed no increase in hair growth against the placebo (unsurprisingly as it is normally only prescribed for men) and the LLLT group’s results were inconclusive but did warrant more investigation.

For more information about treatments that can help to stop female pattern baldness in its tracks, why not book an appointment with one of our female hair loss experts today.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published.